Description
Novimmune is an amino acid solution for parenteral nutrition containing dipeptide alanyl-glutamine. Glutamine is conditionally essential amino acid for use in highly catabolic patients. Glutamine forms 60% of free amino acid pool in the muscles and should be administered as part of amino acid supplementation in parental nutrition
Indications
- Novimmune is indicated as part of an intravenous parenteral nutrition regimen or as a supplement to amino acid solutions in patients in hypercatabolic and/or hypermetabolic states
- For faster recovery of critically ill patients, when oral/enteral route is not available. Like ICU patients, High output fistulas, severe pancreatitis, GI surgery, Bowel obstruction, severe vomiting, severe burns and trauma, and in cancer patients.
Product Variants & Features
| Product | Strength | Presentation | Features |
|---|---|---|---|
| Novimmune | L – Alanyl L- Glutamine Inj. 20% w/v | 50 ml and 100 ml in Glass bottle |
Offers immunomodulatory, anticatabolic/anabolic, gut mucosal barrier-protective and antioxidant actions.
|
Novimmune is administered parallel with parenteral nutrition or enteral nutrition or a combination of both.
Dosage: ESPEN Guideline recommend – Parenteral amino acid should contain 0.2 – 0.4 g/kg/day of L-glutamine (e.g. 0.3 – 0.6 g/kg/day alanyl – glutamine dipeptide)
Infusion rate: Rate of infusion should not exceed 0.1g amino acids/kg body wt./hr
ADMINISTRATION: Solution for infusion after mixture with a compatible infusion solution
| Composition/100ml | Amino Acid | Total Nitrogen | Osmolarity | Total Energy |
|---|---|---|---|---|
| 20 g | 3.2 g | 921 mOsmol/L | 80 Kcal |
Compatible with Amino Acid Solution/ Dextrose solution/ Normal Saline/ Ringer Lactate solution/ Triple chamber bags containing Amino Acid, Glucose & Lipids